Loading...
Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma
BACKGROUND: The recent development of multiple targeted agents for metastatic renal cell carcinoma (mRCC) has changed the treatment paradigm; hence the benefit and optimal timing of cytoreductive nephrectomy is being reevaluated. OBJECTIVE: To determine primary tumor response to treatment with targe...
Saved in:
| Published in: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378833/ https://ncbi.nlm.nih.gov/pubmed/20952123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2010.09.034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|